After The Stock Fell -36.70% Over The Week, Is Galera Therapeutics Inc (NASDAQ: GRTX) Still A Buy?
Galera Therapeutics Inc (NASDAQ:GRTX)’s traded shares stood at 2.36 million during the last session, with the company’s beta value hitting 2.22. At the close of